epigallocatechin gallate has been researched along with sorafenib in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atmodjo, WL; Irawan, A; Prabowo, E; Riwanto, I | 1 |
1 other study(ies) available for epigallocatechin gallate and sorafenib
| Article | Year |
|---|---|
Anti-angiogenic effect of the combination of low-dose sorafenib and EGCG in HCC-induced Wistar rats.
Topics: Animals; Carcinoma, Hepatocellular; Liver Neoplasms; Male; Rats; Rats, Wistar; Sorafenib; Vascular Endothelial Growth Factor A | 2022 |